書籍情報から探す
Phase II Dose Ranging Study of Leflunomide in Japan −Investigation of Efficacy, Safety and Pharmacokinetics−
Yoiehi Ichikawa1, Naoyuki Kamatani2, Makoto Goto3, Hirobumi Kondo4, Terunobu Saito2, Yasuo Suzuki5, Katsutaka Torikai6, Hiroshi Hashimoto7, Nobuyuki Miyasaka8, Hisashi Yamanaka2, Kazuhiko Yamamoto9, Akira Fukao10, Yutaka Mizushima11
1Division of Rheumatology and Allergy, Department of Internal Medicine, St. Joseph's Hospital, 2Institute of Rheumatology, Tokyo Women's Medical University, 3Department of Rheumatology, Tokyo Metropolitan Otsuka Hospital, 4Department of Internal Medicine, Kitasato University School of Medicine, 5Tokai University, Department of Hematology, Oncology and Rheumatology, 6Aichi International Hospital, Department of Rheumatology, 7Department of Internal Medicine and Rheumatology, Juntendo University, 8Department of Bioregulatory Medicine and Rheumatology, Tokyo Medical and Dental University, 9Department of Allergy and Rheumatology, The University of Tokyo, 10Department of Public Health, Yamagata University, 11Institute of Medical Science, St. Marianna University School of Medicine
新薬と臨牀 52 (7) 891-931, 2003.
1Division of Rheumatology and Allergy, Department of Internal Medicine, St. Joseph's Hospital, 2Institute of Rheumatology, Tokyo Women's Medical University, 3Department of Rheumatology, Tokyo Metropolitan Otsuka Hospital, 4Department of Internal Medicine, Kitasato University School of Medicine, 5Tokai University, Department of Hematology, Oncology and Rheumatology, 6Aichi International Hospital, Department of Rheumatology, 7Department of Internal Medicine and Rheumatology, Juntendo University, 8Department of Bioregulatory Medicine and Rheumatology, Tokyo Medical and Dental University, 9Department of Allergy and Rheumatology, The University of Tokyo, 10Department of Public Health, Yamagata University, 11Institute of Medical Science, St. Marianna University School of Medicine
新薬と臨牀 52 (7) 891-931, 2003.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に803円(税込) です。
小児伝染性膿痂疹に対するセフゾン(R)(cefdinir:CFDN)の臨床効果
白濱茂穂1, 杉浦丹2, 奥知三3, 宇野明彦4, 山内卓5, 堀口大輔6, 佐野勉7, 萩原民郎8, 石井眞澄9, 瀧川雅浩10
1:聖隷三方原病院皮膚科, 2:清水市立病院皮膚科, 3:奥皮フ科医院皮膚科, 4:宇野医院皮膚科, 5:山内皮膚科医院皮膚科, 6:堀口皮膚科クリニック皮膚科, 7:佐野ヒフ科クリニック皮膚科, 8:はぎわら皮フ科クリニック皮膚科, 9:石井内科皮膚科医院皮膚科, 10:浜松医科大学皮膚科
新薬と臨牀 52 (7) 1083-1088, 2003.
1:聖隷三方原病院皮膚科, 2:清水市立病院皮膚科, 3:奥皮フ科医院皮膚科, 4:宇野医院皮膚科, 5:山内皮膚科医院皮膚科, 6:堀口皮膚科クリニック皮膚科, 7:佐野ヒフ科クリニック皮膚科, 8:はぎわら皮フ科クリニック皮膚科, 9:石井内科皮膚科医院皮膚科, 10:浜松医科大学皮膚科
新薬と臨牀 52 (7) 1083-1088, 2003.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に803円(税込) です。
